Treatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: Comment on the article by Constantinescu et al

Arthritis Care and Research

Volumn 61, Issue 8, 2009, Pages 1141-1142

  Lee, Susan J ^a   Kremer, Joel ^b   Kavanaugh, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR;

AFRICAN AMERICAN; DEMOGRAPHY; DISEASE DURATION; EDUCATIONAL STATUS; EUROPEAN AMERICAN; HEALTH DISPARITY; HEALTH INSURANCE; HISPANIC; HUMAN; LETTER; MEDICAL RESEARCH; RACE DIFFERENCE; RHEUMATOID ARTHRITIS; SOCIAL STATUS; VISUAL ANALOG SCALE;

AFRICAN AMERICANS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; SOCIAL CLASS; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 68149156216     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24727     Document Type: Letter

References (5)

1. Constantinescu F, Goucher S, Weinstein A, Smith W, Fraenkel L. Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Rheum 2009;61:413-418
2. Jordan JM. Effect of race and ethnicity on outcomes in arthritis and rheumatic conditions. Curr Opin Rheumatol 1999;11:98-103.
3. Callahan LF, Pincus T. Formal education level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum 1988;31:1346-1357 (Pubitemid 19012497)
4. Kavanaugh A, Cohen S, Cush J. The evolving use of TNF inhibitors in rheumatoid arthritis. J Rheumatol 2004;31:1881-1884
5. Greenberg JD, Bingham CO III, Abramson SB, Reed G, Sebaldt RJ, Kremer J. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. Arthritis Rheum 2005;15;53:12-17 (Pubitemid 40216346)